Filing Details
- Accession Number:
- 0001235802-23-000040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-11 17:40:11
- Reporting Period:
- 2023-04-10
- Accepted Time:
- 2023-04-11 17:40:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401040 | Diamedica Therapeutics Inc. | DMAC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1971798 | J. David Wambeke | 301 Carlson Parkway, Suite 210 Minneapolis MN 55305 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Shares, No Par Value Per Share | Acquisiton | 2023-04-10 | 468,750 | $1.60 | 468,750 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (right to buy) | Acquisiton | 2023-04-10 | 140,000 | $0.00 | 140,000 | $1.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 140,000 | 2033-04-09 | No | 4 | A | Direct |
Footnotes
- This option vests with respect to 35,000 common shares on April 10, 2024 and with respect to the remaining 75% of the common shares in 12 as nearly equal as possible quarterly installments commencing three months after the one-year anniversary of the grant date.
Billionaire Hedge Funds
